Helen Godley and Jon Chapman have been appointed as creative directors at global healthcare communications agency Havas Lynx as it looks to build a centre of creative talent equal to its digital capabilities.
Appointed as internal promotions, Godley has been with Lynx for over 10 years working on numerous campaigns, driving business and improving patient outcomes.
Chapman is in his third year with the agency previously leading creative campaigns for the likes of Novartis, Janssen and the University of Manchester.
Of the appointment Chapman said: “The opportunity now to further drive the creative direction of the agency is incredibly exciting. We can continue to produce the highest quality work from our brilliantly diverse studio and demonstrate how we can use our creativity for good. The growing global client base and range of work we have is challenging but equally rewarding and I can't wait to continue and build our creative strength going forward.”
Havas Lynx CEO, Dave Hunt, added: “The brief for our two new creative directors is to drive and develop our creative brilliance. Helen and Jon have demonstrated outstanding dedication and creativity time and time again. They are exceptionally talented and consistently deliver outstanding work for our clients that improve patient lives. Their input has been key part of our success as a business and we are incredibly proud to have them lead our team. I look forward to celebrating their continued success at Lynx.”
Following the announcement both Godley and Chapman will be spending two weeks in New York meeting with the wider Havas network and sharing their ideas.